Literature DB >> 6966583

Antidepressant drugs elevate rat pineal and plasma melatonin.

A Wirz-Justice, J Arendt, A Marston.   

Abstract

Acute administration in the mid-light phase of a number of antidepressant drugs of different pharmacological profiles elevated pineal and plasma melatonin (measured by radioimmunoassay). Following chronic treatment with the tricyclic antidepressant clomipramine, the elevation was significantly reduced. This may be an effect of reduced beta-adrenergic receptor sensitivity after chronic clomipramine administration, analogous to other findings of reduced beta-adrenergic receptor binding and reduced noradrenaline-sensitive adenylate-cyclase response.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966583     DOI: 10.1007/BF01975137

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  18 in total

1.  Determination of rat pineal gland melatonin content by a radioimmunoassay.

Authors:  R J Wurzburger; K Kawashima; R L Miller; S Spector
Journal:  Life Sci       Date:  1976-04-15       Impact factor: 5.037

2.  Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain.

Authors:  D A Bergstrom; K J Kellar
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

3.  Desmethylimipramine-induced decrease in beta-adrenergic receptor binding in rat cerebral cortex.

Authors:  K Sarai; A Frazer; D Brunswick; J Mendels
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

4.  Do tricyclic antidepressants enhance adrenergic transmission?

Authors:  A Frazer; J Mendels
Journal:  Am J Psychiatry       Date:  1977-09       Impact factor: 18.112

5.  Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant.

Authors:  P Simon; Y Lecrubier; R Jouvent; A J Puech; J F Allilaire; D Widlöcher
Journal:  Psychol Med       Date:  1978-05       Impact factor: 7.723

6.  A neuronal receptor sensitivity mechanism in affective illness (a review of evidence).

Authors:  W E Bunney; R M Post; A E Andersen; R T Kopanda
Journal:  Commun Psychopharmacol       Date:  1977

7.  Melatonin assays in body fluids.

Authors:  J Arendt
Journal:  J Neural Transm Suppl       Date:  1978

8.  Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.

Authors:  D A Bergstrom; K J Kellar
Journal:  J Pharmacol Exp Ther       Date:  1979-05       Impact factor: 4.030

9.  Pinealectomy abolishes plasma melatonin in the rat.

Authors:  A J Lewy; M Tetsuo; S P Markey; F K Goodwin; I J Kopin
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

10.  Radioimmunoassay of melatonin: human serum and cerebrospinal fluid.

Authors:  J Adrendt; L Wetterberg; T Heyden; P C Sizonenko; L Paunier
Journal:  Horm Res       Date:  1977
View more
  3 in total

1.  Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmission.

Authors:  P J Cowen; A R Green; D G Grahame-Smith; L E Braddock
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

2.  The hypothalamic and neurohypophysial oxytocin content as influenced by desmethylimipramine in normal and pinealectomized white male rats.

Authors:  J W Guzek; M Juszczak
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Effects of growing tumours on pineal melatonin levels in male rats.

Authors:  V Lapin; A Frowein
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.